Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms, Plasma Cell × defibrotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombotic Microangiopathies 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1

Interventions

Dexamethasone 100 Cyclophosphamide 91 Melphalan 85 Bortezomib 63 Peripheral Blood Stem Cell Transplantation 55 Lenalidomide 50 fludarabine phosphate 45 Filgrastim 45 Busulfan 45 Radiotherapy 34 Antilymphocyte Serum 33 Thalidomide 32 Tacrolimus 30 Mycophenolic Acid 26 fludarabine 23 Cyclosporine 23 Methotrexate 21 Etoposide 21 Calcium Dobesilate 21 Prednisone 20 Whole-Body Irradiation 18 Methylprednisolone 18 pomalidomide 16 carfilzomib 16 Granulocyte Colony-Stimulating Factor 15 sargramostim 14 daratumumab 14 Carmustine 13 Rituximab 12 Interferon-alpha 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00406978 2016-05-10

MPTD

University of Turin, Italy

Phase 1/2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡